Gene Expression Analysis Market to Grow with a CAGR of 9.12% through 2028
Rising application of AI/ML algorithms for statistical
and predictive analyses are expected to drive the Global Gene Expression
Analysis Market growth in the forecast period, 2024-2028.
According to TechSci Research report, “Gene
Expression Analysis Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2028”, the Global Gene
Expression Analysis Market stood at USD 4.76 billion in 2022 and is anticipated
to grow with a CAGR of 9.12% in the forecast period, 2024-2028.
The Global Gene Expression Analysis Market is a
vibrant and promising sector with wide-ranging applications in healthcare,
pharmaceuticals, and life sciences. The market's growth trajectory is
underpinned by the quest for personalized medicine, advances in sequencing
technologies, and the increasing importance of gene expression analysis in
understanding diseases and developing targeted therapies. One of the
primary drivers of the gene expression analysis market is the continuous
advancement in sequencing technologies, particularly next-generation sequencing
(NGS). NGS has revolutionized the field by providing high-throughput,
cost-effective, and highly accurate methods for transcriptome analysis. This
technology enables researchers to simultaneously profile the expression of
thousands of genes across different samples, facilitating a comprehensive
understanding of gene regulation. As sequencing costs continue to decline and
throughput increases, more researchers and organizations can access this
powerful tool, driving market growth. Personalized medicine, which tailors
healthcare and treatment plans to an individual's genetic makeup, is gaining
prominence. Gene expression analysis plays a pivotal role in this field by
helping identify genetic variations and expression patterns that can inform
treatment decisions. Physicians and researchers are increasingly using gene
expression profiling to predict patient responses to specific drugs, identify
disease risk factors, and design targeted therapies. This growing demand for
personalized medicine is a significant driver of the gene expression analysis
market's expansion.
The prevalence of cancer and the need for better
diagnostic tools and therapies have made cancer research a significant driver
of gene expression analysis. Researchers are using gene expression profiling to
identify biomarkers associated with different types of cancer. These biomarkers
can aid in early detection, disease classification, prognosis, and the
development of precision oncology treatments. As the importance of
individualized cancer care grows, the demand for gene expression analysis in
oncology research continues to surge. The biotechnology and pharmaceutical
industries are among the largest contributors to the gene expression analysis
market. These sectors heavily rely on gene expression data for drug discovery,
development, and clinical trials. Understanding the expression patterns of
genes in disease and normal states is crucial for identifying drug targets,
validating potential therapies, and assessing drug safety. As these industries
continue to invest in research and development, the demand for gene expression
analysis tools and services is expected to increase significantly.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Gene
Expression Analysis Market.”
Single-cell RNA sequencing (scRNA-Seq) is a
cutting-edge technology that enables the analysis of gene expression at the
single-cell level. This breakthrough has opened up new avenues for
understanding cell heterogeneity and uncovering rare cell populations within
tissues. Researchers are using scRNA-Seq to study complex biological processes,
such as embryonic development, tissue regeneration, and immune responses. Its
potential applications in disease research and drug discovery make scRNA-Seq a
driving force in the gene expression analysis market.
The Global Gene Expression Analysis Market is
segmented into Product Type, Application , Technique, end-users, regional
distribution, and company.
Based on Technique, the Global Gene Expression
Analysis Market is segmented into
RNA
Expression, Promotor Analysis, Protein Expression & Post Translational
Modification Expression, Others.
Based
on the Technique, the RNA Expression segment emerged as the dominant segment in
the global market for Global Gene Expression Analysis Market in 2022. This can
be attributed to several factors including fundamental role in transcriptomics,
comprehensive gene profiling and diverse applications of RNA expression. It is
invaluable for studying disease mechanisms, identifying biomarkers, and
exploring therapeutic targets. Gene expression analysis is instrumental in
discovering and validating disease biomarkers—specific genes or patterns of
gene expression associated with various diseases. These biomarkers play a
pivotal role in early disease detection, risk assessment, and monitoring
treatment responses. Clinical diagnostics heavily relies on these biomarkers to
enhance disease detection and management. The trend towards personalized
medicine is bolstering the use of gene expression analysis in clinical diagnostics.
By analyzing the gene expression profiles of individual patients, clinicians
can tailor treatment strategies based on the patient's unique genetic
characteristics. This approach maximizes treatment efficacy while minimizing
adverse effects, improving patient outcomes.
Based on Application, the Global Gene Expression
Analysis Market is segmented into
Drug
Discovery and Development, Clinical Diagnostics, Biotechnology and
Microbiology, Others. Based on the Application, the Clinical Diagnostics segment
emerged as the dominant player in the global market for Global Gene Expression
Analysis Market in 2022. Pharmaceutical
companies conduct clinical trials to evaluate the safety and efficacy of new
drugs and treatments. Gene expression analysis is used to assess treatment
responses, monitor patient outcomes, and identify predictive biomarkers. This
information is vital for making informed decisions during clinical trial design
and execution. Gene expression
analysis plays a pivotal role in identifying and validating disease
biomarkers—specific genes or patterns of gene expression associated with
diseases. These biomarkers have significant diagnostic, prognostic, and
therapeutic implications, aiding in patient stratification and personalized
medicine
North America emerged as the dominant player in the
global Gene Expression Analysis Market
in 2022, holding the largest market share.North America, particularly
the United States and Canada, boasts a highly advanced healthcare
infrastructure. This infrastructure supports the integration of gene expression
analysis into clinical practice, research, and drug development.
State-of-the-art laboratories, research institutions, and medical centers
equipped with cutting-edge technologies drive the market's growth. Government agencies in North America, such as the
National Institutes of Health (NIH) in the United States and the Canadian
Institutes of Health Research (CIHR) in Canada, allocate substantial funding to
genomics and gene expression research. These investments support scientific
advancements and stimulate the gene expression analysis market.
Major companies operating in Global Gene
Expression Analysis Market are:
- Merck KGaA
- Genscript Biotech Corporation
- Qiagen
- Bio-Rad Laboratories
- Takara Bio Inc.
- Thermo Fisher Scientific, Inc.
- Promega Corporation
- Agilent Technologies
- Lonza Group Ltd.
- New England Biolabs Inc
Download
Free Sample Report
Customers can also request for 10%
free customization on this report.
“ Liquid
biopsies, which involve the analysis of circulating tumor cells (CTCs) and
cell-free DNA (cfDNA) in blood, are gaining traction in cancer research and
diagnostics. Gene expression analysis of these liquid biopsy samples can
provide valuable information about tumor biology, treatment response, and
disease monitoring. This non-invasive approach is poised to revolutionize
cancer diagnostics and monitoring.
Additionally,
the demand for scRNA-Seq is skyrocketing, propelling the Global Gene Expression
Analysis Market to new heights. It has become an indispensable tool for
researchers seeking a deeper understanding of cellular processes, diseases, and
therapeutic interventions. The continued refinement of scRNA-Seq technologies,
along with efforts to make the technology more accessible and cost-effective,
will likely drive further adoption and innovation in the field of gene
expression analysis.” said Mr. Karan Chechi, Research Director with TechSci
Research, a research-based management consulting firm.
“Gene Expression Analysis Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, 2018-2028 Segmented By Product Type (Instruments,
Services, Others), By Technique (RNA Expression, Promotor Analysis, Protein
Expression & Post Translational Modification Expression, Others), By Application
(Drug Discovery and Development, Clinical Diagnostics, Biotechnology and
Microbiology, Others), By End User (Pharmaceutical and Biotechnology Companies,
Contract Research Organizations (CROs), Academic and Government Research
Institutes, Others) By Region and Competition”, has evaluated the future growth
potential of Global Gene Expression Analysis Market and provides statistics
& information on market size, structure and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global Gene Expression Analysis Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com